Pharmacodynamic Optimization for Treatment of Invasive Candida auris Infection [PublishAheadOfPrint]

Candida auris is an emerging, multidrug-resistant threat. The pharmacodynamics of three antifungal classes against nine C. auris strains was explored using a murine invasive candidiasis model. The total drug median PD target associated with net stasis was a fluconazole AUC/MIC of 26, amphotericin B Cmax/MIC of 0.9, and micafungin AUC/MIC of 54. The micafungin PD targets for C. auris were ≥20-fold lower than other Candida species in this animal model. Clinically relevant micafungin exposures produced the most killing among the three classes.

http://ift.tt/2sxJLxw